Experience with Long-term Glucocorticoid Treatment in Congenital Adrenal Hyperplasia: Growth Pattern Compared with Genetic Height Potential

Abstract

We demonstrated that a hydrocortisone dose of 17.64 +/- 3.60 mg/m2/day in classical CAH had a negative influence on height development for genetic height potential in 8.5 years of follow-up and that it is necessary to use the lowest possible steroid dosage by individualizing the dose.